Promoting Equity for Cancer Screening and Follow-up

NCT04831827 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-10-27

No results posted yet for this study

Summary

This is a randomized trial to assess the efficacy of reminder mechanisms on colorectal cancer (CRC) screening uptake among a cohort of patients who were previously mailed a multitarget stool DNA (mt-sDNA) test and did not complete the screening. Patients will be identified as being due for CRC screening and will be mailed a mt-sDNA kit to their home. Patients who do not complete screening with mt-sDNA within 30 days will be identified and randomized into one of three study arms to receive reminders to complete the mt-sDNA screening. The primary outcome is the rate of completion of screening for colorectal cancer with mt-sDNA test.

Conditions

  • Colorectal (Colon or Rectal) Cancer

Interventions

OTHER

IVR Reminder

Participants will receive an interactive voice reminder (IVR) to complete mt-sDNA screening at day 7 and 21.

OTHER

Phone call from research team

Patients will receive a scripted phone call from the research team to remind them to complete the mt-sDNA screening at day 7 and 21.

OTHER

EHR Portal message

Patients will receive an EHR patient portal message with a scripted message to remind them to complete the mt-sDNA screening at day 7 and 21.

Sponsors & Collaborators

Principal Investigators

  • Chyke Doubeni, MBBS, MPH · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04831827 on ClinicalTrials.gov